NCI State Late Stage Breast Cancer Incidence Rates

This dataset contains Cancer Incidence data for Breast Cancer (Late Stage^) including: Age-Adjusted Rate, Confidence Interval, Average Annual Count, and Trend field information for US States for the average 5 year span from 2018 to 2022. Data are segmented by Females and age (All Ages, Ages Under 50, Ages 50 & Over, Ages Under 65, and Ages 65 & Over), with field names and aliases describing the sex and age group tabulated. For more information, visit statecancerprofiles.cancer.gov Data Notations State Cancer Registries may provide more current or more local data. Trend Rising when 95% confidence interval of average annual percent change is above 0. Stable when 95% confidence interval of average annual percent change includes 0. Falling when 95% confidence interval of average annual percent change is below 0. † Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates. ‡ Incidence Trend data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information. Rates and trends are computed using different standards for malignancy. For more information see malignant. ^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary. Data Source Field Key (2) Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2024 submission). (7) Source: SEER November 2024 submission.本数据集涵盖2018至2022年五年平均跨度内美国各州的晚期乳腺癌（Late Stage^）癌症发病率数据，包含年龄标准化率（Age-Adjusted Rate）、置信区间（Confidence Interval）、年均病例数及趋势字段信息。数据按女性人群及年龄分层（全年龄段、50岁以下、50岁及以上、65岁以下、65岁及以上），字段名与别名均对应所统计的性别与年龄组。 更多信息请访问statecancerprofiles.cancer.gov。 ### 数据说明 各州癌症登记处可提供更新或更本地化的数据。 #### 趋势判定规则 当年度平均百分比变化的95%置信区间大于0时，趋势为上升；当该区间包含0时，趋势为稳定；当区间小于0时，趋势为下降。 † 发病率（年每10万人口病例数）已按2000年美国标准人口进行年龄标准化（SEER区域采用20个年龄组，国家癌症登记计划（National Program of Cancer Registries, NPCR）区域采用19个年龄组）。发病率仅针对浸润性癌（膀胱癌除外，其包含浸润性癌与原位癌），除非另有说明。发病率通过SEER*Stat计算得出。分母的人口数基于经美国国家癌症研究所（National Cancer Institute, NCI）修正的人口普查数据。SEER与NPCR发病率采用美国人口数据文件进行计算。 ‡ 发病率趋势数据来源多样。由于数据可获得年限不同，多数趋势为基于年度百分比变化（APC）的平均年度百分比变化（AAPCs），部分则为通过SEER*Stat计算得出的APC。具体额外信息请查阅各区域的原始来源。发病率与趋势计算采用了不同的恶性肿瘤判定标准，更多信息请参阅malignant。 ^ 晚期病例定义为已判定为区域扩散或远处转移的病例。由于分期编码规则的变更，来自监测、流行病学与最终结果（Surveillance, Epidemiology, and End Results, SEER）数据库的数据采用带扩展区域编码的综合汇总分期（2004年及以后），来自NPCR数据库的数据则采用合并汇总分期。鉴于分期判定的复杂度提升，必要时可采用其他分期变量。 #### 数据来源字段标识 (2) 来源：NPCR SEER*Stat数据库——美国卫生与公众服务部（United States Department of Health and Human Services, HHS）、美国疾病控制与预防中心（Centers for Disease Control and Prevention, CDC）（基于2024年提交数据）。 (7) 来源：SEER 2024年11月提交数据。